feed,title,long_url,short_url
Benzinga,Autolus Therapeutics' CAR T Cell Achieves 100% Complete Remission In Indolent B Cell Non-Hodgkin Cohort,https://benzinga.com/general/biotech/21/06/21526693/autolus-therapeutics-car-t-cell-achieves-100-complete-remission-in-indolent-b-cell-non-hodgkin-co,https://j.mp/3cyKMOL
